focus
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: Unique patient identifier: Experts argue the benefits, pitfalls
Next article: Unique patient identifier: Experts argue the benefits, pitfalls
hotspot
Wikipedia
-
Roche subsidiary Foundation Medicine opens new headquarters
2025-10-02 00:44 -
Why Novartis is going to walk from its acquisition of MorphoSys
2025-10-02 00:05 -
Why the world’s most expensive drug might be worth the price
2025-10-01 23:42 -
Why CTE doesn’t keep Americans from enjoying the Super Bowl
2025-10-01 23:17 -
Readout Newsletter: WuXi and Congress, Boundless Bio, etc.
2025-10-01 23:06 -
Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more
2025-10-01 22:13